iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The company is headquartered in Beijing, Beijing and currently employs 7 full-time employees. The company went IPO on 2024-09-05. The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.